PortfoliosLab logo
LFMD vs. BVS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between LFMD and BVS is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

LFMD vs. BVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in LifeMD, Inc. (LFMD) and Bioventus Inc. (BVS). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

LFMD:

0.47

BVS:

-0.05

Sortino Ratio

LFMD:

1.42

BVS:

0.60

Omega Ratio

LFMD:

1.18

BVS:

1.08

Calmar Ratio

LFMD:

0.54

BVS:

0.04

Martin Ratio

LFMD:

1.41

BVS:

0.12

Ulcer Index

LFMD:

32.91%

BVS:

24.67%

Daily Std Dev

LFMD:

97.67%

BVS:

67.29%

Max Drawdown

LFMD:

-96.24%

BVS:

-95.18%

Current Drawdown

LFMD:

-62.39%

BVS:

-65.85%

Fundamentals

Market Cap

LFMD:

$524.47M

BVS:

$433.32M

EPS

LFMD:

-$0.33

BVS:

-$0.48

PS Ratio

LFMD:

2.24

BVS:

0.76

PB Ratio

LFMD:

107.72

BVS:

2.93

Total Revenue (TTM)

LFMD:

$220.89M

BVS:

$567.70M

Gross Profit (TTM)

LFMD:

$203.16M

BVS:

$381.13M

EBITDA (TTM)

LFMD:

$2.62M

BVS:

$38.13M

Returns By Period

In the year-to-date period, LFMD achieves a 132.12% return, which is significantly higher than BVS's -37.52% return.


LFMD

YTD

132.12%

1M

33.29%

6M

80.66%

1Y

45.26%

3Y*

70.95%

5Y*

51.28%

10Y*

36.82%

BVS

YTD

-37.52%

1M

-13.23%

6M

-46.62%

1Y

-3.67%

3Y*

-11.98%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


LifeMD, Inc.

Bioventus Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

LFMD vs. BVS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LFMD
The Risk-Adjusted Performance Rank of LFMD is 7171
Overall Rank
The Sharpe Ratio Rank of LFMD is 6868
Sharpe Ratio Rank
The Sortino Ratio Rank of LFMD is 7575
Sortino Ratio Rank
The Omega Ratio Rank of LFMD is 7272
Omega Ratio Rank
The Calmar Ratio Rank of LFMD is 7373
Calmar Ratio Rank
The Martin Ratio Rank of LFMD is 6868
Martin Ratio Rank

BVS
The Risk-Adjusted Performance Rank of BVS is 5151
Overall Rank
The Sharpe Ratio Rank of BVS is 4747
Sharpe Ratio Rank
The Sortino Ratio Rank of BVS is 5454
Sortino Ratio Rank
The Omega Ratio Rank of BVS is 5252
Omega Ratio Rank
The Calmar Ratio Rank of BVS is 5252
Calmar Ratio Rank
The Martin Ratio Rank of BVS is 5252
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

LFMD vs. BVS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for LifeMD, Inc. (LFMD) and Bioventus Inc. (BVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current LFMD Sharpe Ratio is 0.47, which is higher than the BVS Sharpe Ratio of -0.05. The chart below compares the historical Sharpe Ratios of LFMD and BVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

LFMD vs. BVS - Dividend Comparison

Neither LFMD nor BVS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

LFMD vs. BVS - Drawdown Comparison

The maximum LFMD drawdown since its inception was -96.24%, roughly equal to the maximum BVS drawdown of -95.18%. Use the drawdown chart below to compare losses from any high point for LFMD and BVS.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

LFMD vs. BVS - Volatility Comparison

LifeMD, Inc. (LFMD) has a higher volatility of 24.16% compared to Bioventus Inc. (BVS) at 18.45%. This indicates that LFMD's price experiences larger fluctuations and is considered to be riskier than BVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

LFMD vs. BVS - Financials Comparison

This section allows you to compare key financial metrics between LifeMD, Inc. and Bioventus Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M20212022202320242025
65.70M
123.88M
(LFMD) Total Revenue
(BVS) Total Revenue
Values in USD except per share items

LFMD vs. BVS - Profitability Comparison

The chart below illustrates the profitability comparison between LifeMD, Inc. and Bioventus Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%80.0%85.0%20212022202320242025
86.8%
67.1%
(LFMD) Gross Margin
(BVS) Gross Margin
LFMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, LifeMD, Inc. reported a gross profit of 57.05M and revenue of 65.70M. Therefore, the gross margin over that period was 86.8%.

BVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Bioventus Inc. reported a gross profit of 83.06M and revenue of 123.88M. Therefore, the gross margin over that period was 67.1%.

LFMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, LifeMD, Inc. reported an operating income of 2.54M and revenue of 65.70M, resulting in an operating margin of 3.9%.

BVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Bioventus Inc. reported an operating income of 4.87M and revenue of 123.88M, resulting in an operating margin of 3.9%.

LFMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, LifeMD, Inc. reported a net income of 1.38M and revenue of 65.70M, resulting in a net margin of 2.1%.

BVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Bioventus Inc. reported a net income of -2.64M and revenue of 123.88M, resulting in a net margin of -2.1%.